Upgrade to SI Premium - Free Trial

Colgate-Palmolive raises dividend and adds Bristol Myers CEO to board

March 12, 2026 4:30 PM

Colgate-Palmolive Company (NYSE: CL) announced a quarterly dividend increase to $0.53 per share from $0.52, effective in the second quarter of 2026. The annualized dividend rate increases to $2.12 per share from $2.08 previously.



The second quarter dividend will be paid May 15, 2026, to shareholders of record on April 20, 2026. The company has paid uninterrupted dividends on its common stock since 1895, according to the press release.



Colgate-Palmolive also elected Christopher Boerner to its board of directors, effective March 15, 2026. Boerner serves as board chair and chief executive officer of Bristol-Myers Squibb Company, a global biopharmaceutical company.



Boerner, 55, became CEO of Bristol Myers Squibb in November 2023 and board chair in April 2024. He previously held executive roles including chief operating officer and chief commercialization officer after joining the pharmaceutical company in 2015.



Steven A. Cahillane informed the board he will not stand for reelection at the annual meeting of stockholders scheduled for May 8, 2026.



"We warmly welcome Chris to the Board and look forward to the contributions his exceptional capabilities will bring to our company," said Noel Wallace, Colgate-Palmolive's chairman, president and CEO. "We express our deepest gratitude to Steve for his dedicated service and invaluable impact on Colgate-Palmolive's success."



Colgate-Palmolive operates in oral care, personal care, home care and pet nutrition, selling products in more than 200 countries and territories under brands including Colgate, Palmolive, Hill's Science Diet and Irish Spring.

Categories

Board Changes